Compare Stocks

Aberdeen International Inc., a resource investment and merchant banking company, focuses on small capitalization companies in the rare metals and renewal energy sectors. The company intends to acquire equity participation in pre-IPO and early-stage public resource companies with undeveloped or undervalued resources and assets; companies in need of managerial, technical, and financial resources; companies undervalued in foreign capital markets; and companies operating in jurisdictions with low to moderate local political risk. The company was formerly known as International Catalyst Ventures Inc. and changed its name to Aberdeen International Inc. in November 2001. Aberdeen International Inc. was incorporated in 1987 and is headquartered in Toronto, Canada.

ARC Document Solutions, Inc., a digital printing company, provides digital printing and document-related services in the United States. It provides managed print services, that places, manages, and optimizes print and imaging equipment in customers' offices, job sites, and other facilities; and cloud-based document management software and other digital hosting services. The company also provides professional services and software services to re-produce and distribute large-format and small-format documents, and specialized graphic color printing. In addition, it engages in the sale and supply of equipment; and provides ancillary services. The company operates service centers in the United States, Canada, China, the United Kingdom, India, and the United Arab Emirates. It serves local restaurant owners, construction subcontractors, international retailers, regional energy companies, and largest school districts, as well as retail, technology, energy, education, hospitality, public utilities, and others. The company was formerly known as American Reprographics Company and changed its name to ARC Document Solutions, Inc. in 2012. ARC Document Solutions, Inc. was founded in 1988 is headquartered in San Ramon, California.

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.

Trenchant Capital Corp., an investment and venture capital company, focuses on providing special situation debt financing to various companies in Canada. The company was formerly known as Echelon Petroleum Corp. and changed its name to Trenchant Capital Corp. in May 2017. Trenchant Capital Corp. was incorporated in 2009 and is headquartered in Vancouver, Canada.

TCW Strategic Income Fund, Inc. is a close-ended balanced mutual fund launched by The TCW Group, Inc. The fund is managed by TCW Investment Management Company. It invests in the public equity and fixed income markets of the United States. The fund makes its investments in securities of companies operating across diversified sectors. For its equity investments, it seeks to invest in growth and value stocks of companies. The fund's fixed income investments are comprised of mortgage related securities, asset-backed securities, money market securities, convertible securities, high yield bonds, collateralized debt obligations (CDOs), and securities issued or guaranteed by the United States Government, its agencies and instrumentalities. It benchmarks the performance of its portfolio against the S&P 500 Index, NASDAQ, and a customized benchmark comprised of Barclays U.S. Aggregate Bond Index, Citigroup High Yield Cash Pay Index, S&P 500 Index, and BofA Merrill Lynch All Convertibles All Qualities. The fund was previously known as TCW Convertible Securities Fund, Inc. TCW Strategic Income Fund, Inc. was formed on January 13, 1987 and is domiciled in the United States.